HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The invasive proteome of glioblastoma revealed by laser-capture microdissection.

AbstractBACKGROUND:
Glioblastomas are heterogeneous tumors composed of a necrotic and tumor core and an invasive periphery.
METHODS:
Here, we performed a proteomics analysis of laser-capture micro-dissected glioblastoma core and invasive areas of patient-derived xenografts.
RESULTS:
Bioinformatics analysis identified enriched proteins in central and invasive tumor areas. Novel markers of invasion were identified, the genes proteolipid protein 1 (PLP1) and Dynamin-1 (DNM1), which were subsequently validated in tumors and by functional assays.
CONCLUSIONS:
In summary, our results identify new networks and molecules that may play an important role in glioblastoma development and may constitute potential novel therapeutic targets.
AuthorsThomas Daubon, Joris Guyon, Anne-Aurélie Raymond, Benjamin Dartigues, Justine Rudewicz, Zakaria Ezzoukhry, Jean-William Dupuy, John M J Herbert, Frédéric Saltel, Rolf Bjerkvig, Macha Nikolski, Andreas Bikfalvi
JournalNeuro-oncology advances (Neurooncol Adv) 2019 May-Dec Vol. 1 Issue 1 Pg. vdz029 ISSN: 2632-2498 [Electronic] England
PMID32642662 (Publication Type: Journal Article)
Copyright© The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: